Catalent Investor Relations Material
Latest events
Q1 2024
Catalent
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Catalent Inc
Access all reports
Catalent, Inc. is a global contract development and manufacturing organization and provider of research, analytical and clinical services. Catalent offers integrated discovery, development and manufacturing solutions including late stage clinical, sterile process design, commercial production and development solutions for biologics and over-the-counter health drug products.
The company also provides comprehensive pharmaceutical services through established early phase development capabilities in small molecule API drug development and late phase clinical development capabilities in global multi-site clinical trials. In addition to biopharmaceuticals and OTC services, Catalent provides an integrated suite of R&D services, including protein chemistry and analytical testing to support non-biotechnology clients developing diagnostics for use in the clinical laboratory. Catalent, Inc. was incorporated in 2007 and is headquartered in Somerset, New Jersey.
Key slides for Catalent Inc
Q1 2024
Catalent Inc
Q1 2024
Catalent Inc
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States